Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Oct;39(5):e23-35.
doi: 10.1053/j.seminoncol.2012.08.013.

Senior adult oncology: three cases of advanced cancer in patients of advanced age

Gloria J Morris  1 , Kristine Swartz, Andrew E Chapman, Stuart M Lichtman, Jason S Levitz, Farhad Ravandi, Kathryn R Chan
Affiliations
Case Reports

Senior adult oncology: three cases of advanced cancer in patients of advanced age

Gloria J Morris et al. Semin Oncol. 2012 Oct.

Erratum in

  • Semin Oncol. 2013 Feb;40(1):134
No abstract available

PubMed Disclaimer

Figures

Figure One
Figure One
CAT scan of the abdomen with oral and intravenous contrast, showing liver in (a) axial view, and (b) coronal view. Courtesy of Dave Soltis, Advanced Imaging Specialists, Scranton, PA.
Figure One
Figure One
CAT scan of the abdomen with oral and intravenous contrast, showing liver in (a) axial view, and (b) coronal view. Courtesy of Dave Soltis, Advanced Imaging Specialists, Scranton, PA.
Figure Two
Figure Two
(Panel A) Peripheral blood smear, Hematoxylin and Eosin stain, 10x magnification, showing left-shifted atypical myelomonocytic proliferation of white blood cells. (Panel B) Cytogenetic study showing normal karyotype. Courtesy of Genoptix Medical Laboratory, Inc., Carlsbad, CA.
Figure Two
Figure Two
(Panel A) Peripheral blood smear, Hematoxylin and Eosin stain, 10x magnification, showing left-shifted atypical myelomonocytic proliferation of white blood cells. (Panel B) Cytogenetic study showing normal karyotype. Courtesy of Genoptix Medical Laboratory, Inc., Carlsbad, CA.
Figure Three
Figure Three
(Panel A) Hematoxylin and Eosin stain of lumpectomy specimen, at 10X magnification; (Panel B) Hematoxylin and Eosin stain of lumpectomy specimen, at 40X magnification; (Panel C) Hematoxylin and Eosin stain of mastectomy specimen, at 10X magnification, showing lymph node metastases; (Panel D) Hematoxylin and Eosin stain of mastectomy specimen, at 40X magnification. Immunohistochemistry (IHC) was negative for expression of estrogen receptor, progrestoerone receptor, or HER-2-neu expression. Courtesy of Dr. Thomas Himes, Department of Pathology, Community Medical Center, Scranton, PA.
Figure Three
Figure Three
(Panel A) Hematoxylin and Eosin stain of lumpectomy specimen, at 10X magnification; (Panel B) Hematoxylin and Eosin stain of lumpectomy specimen, at 40X magnification; (Panel C) Hematoxylin and Eosin stain of mastectomy specimen, at 10X magnification, showing lymph node metastases; (Panel D) Hematoxylin and Eosin stain of mastectomy specimen, at 40X magnification. Immunohistochemistry (IHC) was negative for expression of estrogen receptor, progrestoerone receptor, or HER-2-neu expression. Courtesy of Dr. Thomas Himes, Department of Pathology, Community Medical Center, Scranton, PA.
Figure Three
Figure Three
(Panel A) Hematoxylin and Eosin stain of lumpectomy specimen, at 10X magnification; (Panel B) Hematoxylin and Eosin stain of lumpectomy specimen, at 40X magnification; (Panel C) Hematoxylin and Eosin stain of mastectomy specimen, at 10X magnification, showing lymph node metastases; (Panel D) Hematoxylin and Eosin stain of mastectomy specimen, at 40X magnification. Immunohistochemistry (IHC) was negative for expression of estrogen receptor, progrestoerone receptor, or HER-2-neu expression. Courtesy of Dr. Thomas Himes, Department of Pathology, Community Medical Center, Scranton, PA.
Figure Three
Figure Three
(Panel A) Hematoxylin and Eosin stain of lumpectomy specimen, at 10X magnification; (Panel B) Hematoxylin and Eosin stain of lumpectomy specimen, at 40X magnification; (Panel C) Hematoxylin and Eosin stain of mastectomy specimen, at 10X magnification, showing lymph node metastases; (Panel D) Hematoxylin and Eosin stain of mastectomy specimen, at 40X magnification. Immunohistochemistry (IHC) was negative for expression of estrogen receptor, progrestoerone receptor, or HER-2-neu expression. Courtesy of Dr. Thomas Himes, Department of Pathology, Community Medical Center, Scranton, PA.
Figure Four
Figure Four
Example of a clinical evaluation form for Senior Oncology patients. Reference 29, Posiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-8.
Figure Four
Figure Four
Example of a clinical evaluation form for Senior Oncology patients. Reference 29, Posiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-8.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. [accessed 8/9/11];National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN), Senior Adult Oncology, Version 2. 2011 http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf,
    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
    1. Hippocratic oath. The Hippocratic Oath. In: North Michael., translator and editor. National Library of Medicine, National Institutes of Health. [Accessed 8/3/11]. http://www.nlm.nih.gov/hmd/greek/greek_oath.html. Retrieved 2009-02-02.
    1. The Hippocratic Oath. [accessed 8/3/11]; http://en.wikipedia.org/wiki/Hippocratic_Oath,
    1. Jonker DJ, Maroun JA, Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. British Journal of Cancer. 2000;82(11):1789–1794. - PMC - PubMed

Publication types